Surge Therapeutics
Focused. Immunotherapy. Delivered.
Cambridge, United States · Founded 2018 · $58.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- surgetx.com
- Total Funding
- $58.0M
- Last Round
- $32.0M Series BJul 2023
- Rounds
- 2
About
Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recurrence by locally releasing cancer immunotherapy.
Summary
Surge Therapeutics is a Biotech company based in Cambridge, United States, founded in 2018. It has raised $58.0M in total across 2 rounds, most recently a $32.0M Series B round in Jul 2023. Investors include Camford Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...
Biotechnology company that discovers and develops medicines for serious, life-threatening disease...